Searched for
LIFESCIENCES INFRASTRUCTURE
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...03 Jun, 2026, 10.16 PM IST- Dividend alert! Last date to buy Bajaj Auto, GSK Pharma and 10 other stocks for solid payouts. Details hereTwelve companies are set to go ex-dividend on Friday, offering shareholders payouts totaling over Rs 250. Bajaj Auto leads with a Rs 150 pe...27 May, 2026, 08.33 AM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...24 May, 2026, 12.23 PM IST
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...22 May, 2026, 04.40 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...20 May, 2026, 10.41 PM IST
- Ahead of Market: 10 things that will decide stock market action on ThursdayBenchmark indices closed marginally higher on Wednesday, led by gains in banking and auto shares, while IT and FMCG stocks capped advances....20 May, 2026, 10.31 PM IST
- Zydus Lifesciences to pursue acquisitions in specialty, rare diseasesZydus Lifesciences is set to acquire US firm Assertio Holdings for $166.40 million. This move aims to build a strong specialty oncology bus...19 May, 2026, 08.58 PM IST
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...14 May, 2026, 11.15 AM IST
- Stocks in news: HAL, TMPV, Bharti Airtel, Anant Raj, Zydus Life, Tata MotorsIndian markets experienced a volatile yet stable session after a sharp sell-off, with the Nifty showing resilience. Key companies like HAL,...14 May, 2026, 06.45 AM IST
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...14 May, 2026, 01.22 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the stock market, everything has to be seen in context. The most noticeable thing these past few days is that there is not much Gulf-rel...13 May, 2026, 11.39 PM IST
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...02 May, 2026, 11.56 PM IST
- Most hated stocks: FIIs dumping these 146 companies without a break for 4 straight quarters. Do you own any?Foreign institutional investors have been consistently selling shares in 146 Indian companies for four consecutive quarters. This selling s...24 Apr, 2026, 09.03 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...22 Apr, 2026, 10.08 PM IST
- Multibagger hunter Vijay Kedia buys 4.5% in SME Mahamaya Lifesciences; adds smallcap SPML Infra in Q4Ace investor Vijay Kedia boosted his smallcap exposure in Q4 by acquiring 4.53% in Mahamaya Lifesciences and 1.88% in SPML Infra. Kedia, kn...21 Apr, 2026, 04.06 PM IST
- Cerestra aspires to be a “Passive Infrastructure Partner” of choice for Education and Lifesciences IndustriesApart from being a modern city with state of the art infrastructure, Hyderabad has been at the forefront of providing better Healthcare to ...03 Mar, 2017, 04.08 PM IST
Load More
